Treatment Information


Lung Cancer treatment details. Chemotherapy.

Tufts Medical Center, Boston, MA, United States.

Survival: monthsCountry:United States
Toxiciy Grade:4City/State/Province:Boston, MA
Treatments:ChemotherapyHospital:Tufts Medical Center
Date:Nov 2008


Patients: This study involved 344 patients with stage IB non-small cell lung cancer. These patients ranged in age from 34 to 81 years of age. All had previously had surgery within 4-8 weeks of starting this study.

Treatment: Patients were treated with either the chemotherapy drugs paclitaxel and carboplatin, or no drug therapy (just observation).

Toxicity: Grade 4 toxicities were neutropenia, hyperglycemia, malaise/fatigue, dyspnea (shortness of breath), hypotension and phlebitis. The most common grade 4 toxicity was neutropenia, occurring in 38% of patients treated with the chemotherapy drugs.

Results: The median overall survival was 95 months in the chemotherapy group and 78 months in the observation group.

Correspondence: Dr. Gary M. Strauss